Billix ™ M
Billix™ M is a dual-action anti-allergic formulation developed to assist healthcare professionals in the management of allergic conditions involving both histamine and leukotriene-mediated inflammatory pathways. The combination supports comprehensive allergy care in patients presenting with persistent respiratory or dermatological hypersensitivity symptoms.
The formulation helps maintain symptom control while supporting patient comfort during physician-guided therapy.
Dosage Form
Tablets
• Therapeutic Category
Anti-Allergic Combination
• Pack Size
10 × 10 Alu-Alu
• Route of Administration
Oral
• Formulated For
Physician-directed allergy management
• Brand
Indigammy
Billix™ M combines Bilastine, a second-generation non-sedating antihistamine, with Montelukast, a leukotriene receptor antagonist, providing complementary mechanisms for allergy management.
Bilastine selectively blocks peripheral H1 receptors, helping reduce histamine-mediated symptoms such as sneezing, itching, nasal irritation, and urticarial discomfort.
Montelukast works by inhibiting leukotriene receptors involved in inflammatory and hypersensitivity responses, assisting in the management of persistent allergic inflammation affecting both respiratory pathways and skin.
The formulation is designed to support skin health and airway comfort in allergic conditions requiring multi-pathway therapeutic intervention.